Skip to main content
Premium Trial:

Request an Annual Quote

Jamie Oliver, Stephen Mon Wei Chang, Alan Barber, Linda McGoldrick, and D. Craig Allred

Premium

Ingenium Research has named Jamie Oliver chief operations officer and head of development.

Oliver has served for seven years as vice president of clinical development for public and private biotechnology companies, Ingenium said. Most recently, he was the associate director of medical affairs with ClinTrials Research (now Inveresk), where he served as the medical monitor for numerous national and international clinical studies. Prior to this, Oliver directed the research operations of a large non-profit hemodialysis corporation, Ingenium said.


MultiCell Technologies announced last week that Stephen Mon Wei Chang has joined the company’s scientific advisory board.

Chang currently serves as the CEO of Astral Therapeutics. He was the chief science officer and vice president of Canji/Schering Plough Research Institute from 1998 to 2004. From 1995 to 1997, he served as director of research for Chiron Viagene and Chiron, and prior to this he was the director of viral and genetic therapeutics and senior principal scientist for Viagene, MultiCell said.

Chang earned his PhD in biological chemistry, molecular biology, and biochemistry from the University of California, Irvine.


BioTrove has appointed Alan Barber chief financial officer, the company said last week.

Barber joins BioTrove from Omnisonics Medical Technologies, where he served as CFO. Barber has also previously served as the CFO at Innovation Chain, MyWay.com, Medical Foods, and Ergo Science. He is a CPA and has a BS in accounting from Florida State University.


Charles River Laboratories said last week that Linda McGoldrick has been elected to its Board of Directors.

McGoldrick is currently the chairman of Financial Health Associates International, which she founded in 1985. From 2001 to 2003, she served as senior vice president and national development director for healthcare and life sciences industry practices at Marsh-MMC. She has also been a board member and international operations and marketing director for Veos, according to Charles River Laboratories.

McGoldrick earned an MBA from the Wharton School of Business and an MSW in healthcare from the University of Pennsylvania.


ChromaVision Medical Systems, which provides automated cell-imaging systems for pathology, diagnostics, and drug discovery, announced last week that D. Craig Allred has been named a consulting pathologist and charter member of ChromaVision’s new medical advisory board.

Allred is currently a professor and director of pathology at the Breast Care Center, Baylor College of Medicine. He holds an MD from the University of Utah, and is a former resident in anatomic pathology and fellow in immunopathology at the University of Connecticut Health Center.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.